|
Dr. Cabral-Lilly was formerly Senior Director of Pharmaceutical Development at Control Delivery Systems (CDS), where she was responsible for chemistry, manufacturing and controls programs for several drug delivery products in clinical development. Prior to joining CDS, Dr. Cabral-Lilly was at Elan Pharmaceuticals where she directed the Analytical Research and Development Group. She has authored numerous scientific publications and is credited as inventor on several patents. Dr. Cabral-Lilly was an instructor at Boston University School of Medicine. She earned her Ph.D. from Boston University and was a post-doctoral fellow at Brandeis University. | 